Regulatory round-up: 20 July 2026

Medicines regulators in major international markets have issued a mix of approvals, safety communications, recalls, enforcement actions and procedural updates over the past week.

The latest round-up includes approvals and drug-trial information from the US Food and Drug Administration (FDA), safety and review postings from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), direct healthcare professional communications from Swissmedic, recalls and regulatory notices from Singapore’s Health Sciences Authority (HSA), and compliance and market-action updates from the Therapeutic Goods Administration (TGA) in Australia. The table below summarizes official human medicines regulatory updates from the past seven days.